Howard Weiss, Vice President of Government Affairs at EmblemHealth

In this episode, Joseph Pinto, Vice President of Pharmacy Operations at Mount Sinai Health System, discusses a systemwide modernization of pharmacy operations that improved resiliency, automation, and cost performance. He also outlines 2026 priorities around AI enablement, specialty and gene therapies, and balancing financial stewardship with access and safety.

In this episode, Dr. Nicole Fox, Associate Chief Medical Officer and Medical Director of Pediatric Trauma at Cooper University Health Care, discusses workforce fatigue, physician well being, and engagement as top priorities in trauma care. She shares how Cooper is investing in peer support, coaching, and culture to sustain teams, strengthen leadership, and prepare for the future of healthcare.

In this episode, Dr. Nirmit Kothari, Associate Chief Medical Officer at Baptist Memorial Hospital Memphis, shares the key trends shaping 2026, including AI integration, value based care, and workforce sustainability. He also discusses how focused efforts on patient flow, clinician engagement, and bottom up innovation have driven strong performance and growth at his organization.

In this episode, Michael Evans, RPh, MBA, FASHP, Chief Pharmacy Officer for Enterprise Pharmacy at Geisinger, discusses key pharmacy priorities including biosimilar adoption, the impact of the Inflation Reduction Act, cell and gene therapy readiness, and strategies to expand access and strengthen pharmacy operations.

In this episode, Roger Hartl, MD, Hansen-MacDonald Professor of Neurological Surgery, Director of Neurosurgery Spine at Weill Cornell Medicine, and Neurosurgical Director of Och Spine at NewYork-Presbyterian/Weill Cornell Medical Center, shares key trends shaping spine care, including AI, biologics, minimally invasive surgery, and the importance of multidisciplinary collaboration and patient communication.

In this episode, Dr. Gbolahan Okubadejo, a board certified spinal and orthopedic surgeon based in New York City, discusses common misconceptions about spine surgery, advances in minimally invasive and robotic techniques, and how technology is improving outcomes.

In this episode, Howard Weiss, Vice President of Government Affairs at EmblemHealth, discusses how payer provider collaboration, community based programs, and value focused partnerships can improve affordability and outcomes. He also shares how consumer pressure, regulatory scrutiny, and responsible use of AI are shaping health plan strategy and margins in 2026.

This episode, recorded live at the Becker’s 13th Annual CEO + CFO Roundtable, features Shirin Hasan, Research Manager at Endeavor Health, as she discusses managing large-scale clinical trials and NIH-funded research across multiple hospitals. She shares insights on improving operational efficiency, leveraging technology and AI, and designing high-impact workflows to enhance both patient care and research outcomes.

In this episode, Alexander Vaccaro, MD, PhD, MBA, President of Rothman Orthopaedics, joins the podcast to discuss how agentic AI is making spine surgery safer and more precise. He shares his priorities heading into 2026, including supporting professional and organic growth, expanding geographically, and navigating the evolving landscape of medical malpractice while continuing to advance high-quality spine care.

In this episode, Michael Evans, RPh, MBA, FASHP, Chief Pharmacy Officer for Enterprise Pharmacy at Geisinger, discusses key pharmacy priorities including biosimilar adoption, the impact of the Inflation Reduction Act, cell and gene therapy readiness, and strategies to expand access and strengthen pharmacy operations.